Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Endocrinology
|
September 19, 2007
Finding GAD: early detection of beta-cell injury
Simon A Hinke
Science Signaling
|
August 27, 2009
Epac2: a molecular target for sulfonylurea-induced insulin release
Simon A Hinke
Current Opinion in Molecular Therapeutics
|
October 3, 2008
Diamyd, an alum-formulated recombinant human GAD65 for the prevention of autoimmune diabetes
Simon A Hinke
The Journal of Physiology
|
June 8, 2004
Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal
Simon A Hinke, Karine Hellemans, Frans C Schuit
Advances in Experimental Medicine and Biology
|
May 17, 2006
Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM)
Simon A Hinke, Raymond A Pederson, Christopher H S McIntosh
Biochemical and Biophysical Research Communications
|
August 7, 2002
Rebuttal to Deacon and Holst: "Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1" versus "Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective"
Hans-Ulrich Demuth, Simon A Hinke, Raymond A Pederson, et al.
Molecular Pharmacology
|
November 5, 2016
State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281
Marie-Laure Rives, Morena Shaw, Bin Zhu, et al.
Biochemistry
|
March 12, 2003
Structure-function analysis of a series of novel GIP analogues containing different helical length linkers
Susanne Manhart, Simon A Hinke, Christopher H S McIntosh, et al.
The Journal of Biological Chemistry
|
September 11, 2007
MyRIP anchors protein kinase A to the exocyst complex
April S Goehring, Benjamin S Pedroja, Simon A Hinke, et al.
Biochemical Pharmacology
|
June 9, 2004
Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness
Dominique Delmeire, Daisy Flamez, Karen Moens, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Endocrinology
|
September 19, 2007
Finding GAD: early detection of beta-cell injury
Simon A Hinke
Science Signaling
|
August 27, 2009
Epac2: a molecular target for sulfonylurea-induced insulin release
Simon A Hinke
Current Opinion in Molecular Therapeutics
|
October 3, 2008
Diamyd, an alum-formulated recombinant human GAD65 for the prevention of autoimmune diabetes
Simon A Hinke
The Journal of Physiology
|
June 8, 2004
Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal
Simon A Hinke, Karine Hellemans, Frans C Schuit
Advances in Experimental Medicine and Biology
|
May 17, 2006
Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM)
Simon A Hinke, Raymond A Pederson, Christopher H S McIntosh
Biochemical and Biophysical Research Communications
|
August 7, 2002
Rebuttal to Deacon and Holst: "Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1" versus "Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective"
Hans-Ulrich Demuth, Simon A Hinke, Raymond A Pederson, et al.
Molecular Pharmacology
|
November 5, 2016
State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281
Marie-Laure Rives, Morena Shaw, Bin Zhu, et al.
Biochemistry
|
March 12, 2003
Structure-function analysis of a series of novel GIP analogues containing different helical length linkers
Susanne Manhart, Simon A Hinke, Christopher H S McIntosh, et al.
The Journal of Biological Chemistry
|
September 11, 2007
MyRIP anchors protein kinase A to the exocyst complex
April S Goehring, Benjamin S Pedroja, Simon A Hinke, et al.
Biochemical Pharmacology
|
June 9, 2004
Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness
Dominique Delmeire, Daisy Flamez, Karen Moens, et al.
Page
of 4